The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Assessment of hematological toxicity in patients with advanced neuroendocrine tumors and extensive/innumerable bone metastases undergoing lutetium-177 DOTATATE treatment.
 
Osama M Mosalem
No Relationships to Disclose
 
Tucker Coston
No Relationships to Disclose
 
Tanmayi Pai
(OPTIONAL) Uncompensated Relationships - Alexion Pharmaceuticals; Seagen
 
Bassam Bassam Sonbol
Consulting or Advisory Role - Novartis Biociencias
Research Funding - Lilly (Inst); Taiho Oncology (Inst)
 
Ephraim E. Parent
Consulting or Advisory Role - Blue Earth Diagnostics
 
Jason R. Young
No Relationships to Disclose
 
Geoffrey Johnson
Leadership - Green Clinic (I); Nucleus RadioPharma (Inst)
Consulting or Advisory Role - AstraZeneca (Inst); Blue Earth Diagnostics (Inst); Curium Pharma (Inst); MedTrace (Inst); MorphImmune (Inst); Novartis (Inst); Siemens Healthineers (Inst); Viewpoint Molecular Targeting (Inst); Viewpoint Molecular Targeting (Inst); Z-Alpha (Inst)
Research Funding - Clarity Pharmaceuticals (Inst); Clovis Oncology (Inst); MedTrace (Inst); Novartis (Inst); Pfizer (Inst); Viewpoint Molecular Targeting (Inst); Viewpoint Molecular Targeting (Inst)
Patents, Royalties, Other Intellectual Property - Patents on Radiopharmaceuticals; Patents on Radiopharmaceuticals (Inst)
 
Ayse T. Kendi
Consulting or Advisory Role - Novartis
Research Funding - Endocyte (Inst)
 
Thorvardur Ragnar Halfdanarson
Consulting or Advisory Role - Advanced Accelerator Applications (Inst); Camurus (Inst); Crinetics Pharmaceuticals (Inst); Ipsen (Inst); ITM Isotope Technologies Munich (Inst); Tersera; Viewpoint Molecular Targeting (Inst)
Research Funding - Advanced Accelerator Applications (Inst); Camurus (Inst); Crinetics Pharmaceuticals (Inst); ITM Isotope Technologies Munich (Inst); Novartis (Inst); Thermo Fisher Scientific (Inst); Turnstone Bio (Inst)
 
Jason S. Starr
Consulting or Advisory Role - Cancer Expert Now; Helsinn Therapeutics; Ipsen; Natera; Pfizer; Taiho Oncology; Tempus; Tersera
Research Funding - Amgen (Inst); Arcus Biosciences (Inst); Camurus (Inst); Incyte (Inst); Leap Therapeutics (Inst); Macrogenics (Inst); Merus (Inst); Molecular Templates (Inst); Rafael Pharmaceuticals (Inst)
Travel, Accommodations, Expenses - Camurus